Harmony Biosciences Inc. (HRMY)
NASDAQ: HRMY
· Real-Time Price · USD
34.05
-0.04 (-0.12%)
At close: May 09, 2025, 3:59 PM
34.50
1.32%
After-hours: May 09, 2025, 05:04 PM EDT
-0.12% (1D)
| Bid | 32.39 |
| Market Cap | 1.96B |
| Revenue (ttm) | 744.85M |
| Net Income (ttm) | 152.72M |
| EPS (ttm) | 2.62 |
| PE Ratio (ttm) | 13 |
| Forward PE | 8.28 |
| Analyst | Buy |
| Ask | 34.5 |
| Volume | 437,215 |
| Avg. Volume (20D) | 752,503 |
| Open | 34.00 |
| Previous Close | 34.09 |
| Day's Range | 33.88 - 34.45 |
| 52-Week Range | 26.47 - 41.61 |
| Beta | 0.82 |
About HRMY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HRMY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HRMY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Harmony Biosciences has released their quartely earnings
on May 6, 2025:
2 months ago
-9.64%
Harmony Biosciences shares are trading lower after...
Unlock content with
Pro Subscription
6 months ago
-18.53%
Harmony Biosciences shares are trading lower after the company announced a public offering of up to 8 million shares of common stock by selling shareholders Marshman Fund Trust II and Valor IV Pharma Holdings.
